Profit Over Patients: Minnesota Senators Launch Legislative Push to Curb Private Equity’s Grip on Autism Therapy

By Investigative Staff

In a major shift for the Minnesota legislature, two prominent state senators are spearheading a campaign to impose strict regulatory oversight on the autism therapy industry. The move follows a scathing investigation by The 74, which revealed how private equity firms have systematically consolidated local autism therapy centers, prioritizing rapid profit extraction over the well-being of vulnerable children.

State Senators Zaynab Mohamed and Scott Dibble, both representing Minneapolis, have announced they will introduce legislation aimed at exposing the financial structures of these providers and mandating transparency in the healthcare sector. The proposal seeks to halt what critics describe as an unchecked "Wall Street takeover" of essential pediatric services.

The Rising Tide of Private Equity in Healthcare

Over the past decade, the landscape of autism therapy—specifically Applied Behavior Analysis (ABA)—has shifted dramatically. Once dominated by independent, local “mom-and-pop” clinics, the field is now increasingly controlled by large, for-profit networks backed by private equity capital.

These investment firms often acquire smaller practices, consolidating them into larger entities to capture economies of scale and maximize Medicaid billing. According to data analyzed by The 74, this aggressive expansion has seen Medicaid reimbursements for ABA therapy skyrocket from approximately $400 million in 2019 to nearly $2 billion by 2024.

"This report is outrageous," said Sen. Zaynab Mohamed. "The idea that Wall Street investors are exploiting these programs for profit is infuriating. We are talking about children’s lives and public taxpayer dollars, not a stock market play for short-term gain."

Chronology of a Crisis: From Clinical Care to Corporate Commodity

The transformation of autism services did not happen overnight. To understand the current push for regulation, one must examine the timeline of the industry’s professionalization and subsequent commodification.

• Pre-2015: ABA services are largely provided by independent therapists and community-based organizations. Oversight is decentralized, and the market is relatively stable.
• 2015–2019: Private equity begins identifying autism therapy as a lucrative, recession-proof investment. Acquisitions accelerate as firms recognize the steady, government-backed revenue stream provided by Medicaid.
• 2019: Medicaid reimbursements for ABA hit the $400 million mark. Critics begin to raise concerns regarding the efficacy of the treatment, which often requires up to 40 hours of intensive "behavioral conditioning" per week for children as young as two.
• 2020–2023: The "Big Box" model takes hold. Companies prioritize scaling their operations, often moving into states with the most favorable reimbursement rates.
• 2024: National spending on ABA hits $2 billion. The 74 publishes its investigation, highlighting the correlation between private equity ownership and concerns regarding patient outcomes.
• Late 2025–2026: Following a national outcry over Medicaid fraud and reports of poor care, Minnesota senators signal a legislative crackdown, drawing parallels to previous failures in the nursing home and assisted living sectors.

The Data: A System Under Strain

The financial data regarding these acquisitions is stark. An analysis of U.S. Centers for Medicare and Medicaid Services (CMS) records reveals that private equity firms currently own nearly half of the 50 companies with the highest billing claims in the country. During a six-year window, these specific companies accounted for a staggering $3.1 billion of the $7 billion in total billing analyzed.

Beyond the sheer volume of claims, the clinical efficacy of the services provided has come under fire. Recent academic research has raised alarms regarding the "evidence base" for ABA. Some studies suggest that the rigid application of the therapy, which aims to "extinguish" autistic traits, may be linked to increased rates of PTSD and psychiatric hospitalizations among patients.

For many advocates, the intersection of questionable medical outcomes and high-pressure financial extraction creates a "perfect storm" for potential neglect.

Official Responses and the "Ownership Transparency" Mandate

Sen. Scott Dibble, who has previously championed legislation to require disclosure of ownership for nursing homes, views the situation as a direct threat to the public trust. Drawing on a recent investigation by state healthcare monitors—which found that 79% of abuse and neglect complaints in long-term care facilities involved for-profit entities—Dibble argues that transparency is the first step toward accountability.

"It’s not enough to have a P.O. box in New Jersey," Dibble remarked. "I think we’re entitled to know: who owns this particular entity, what else do they own, and how well have they provided services?"

Dibble’s proposed legislation seeks to implement a “liquor license-style” vetting process. Under this framework, companies seeking to provide autism services would be required to prove their operational history, demonstrating a track record of ethical conduct before being granted the privilege of accessing public funds.

Furthermore, the senators are advocating for a “medical loss ratio” for therapy providers—a requirement that a specific, high percentage of every dollar reimbursed must be spent directly on patient care, rather than on administrative overhead or investor dividends.

Implications for Families and the Future of Care

The legislative push arrives at a sensitive time. With the "One Big Beautiful Bill Act" putting significant pressure on Medicaid spending, Minnesota faces the challenge of maintaining essential benefits while preventing the systemic waste identified by federal auditors.

The situation has been further complicated by the political landscape. Last winter, the Trump administration utilized the issue of Medicaid fraud in Minnesota as a justification for increased immigration enforcement, claiming that "abuse" was being perpetrated by immigrant-led organizations. However, the data suggests a broader, systemic issue that transcends specific demographics: the rise of the private equity business model.

The Human Cost

When these firms reach their target profit levels, they often sell the companies or move on to new ventures. Critics argue this leaves the local clinics with significant debt, often resulting in bankruptcy or, at the very least, a reduction in the quality of care. For families of children with autism, this instability is catastrophic. When a provider closes its doors, parents are often left with no support system for their children, who rely on the continuity of care for their development.

A New Regulatory Horizon

The proposed legislation represents a fundamental re-evaluation of how the state views private healthcare providers. By shifting the burden of proof onto the companies, Mohamed and Dibble hope to deter firms that view pediatric therapy as a short-term financial asset.

"This kind of aggressive, super-sized profit motive is totally inappropriate in these settings," Dibble said. "It incentivizes behaviors that don’t support the public’s interest or the health of our children. We are going to ensure that if you are going to operate in Minnesota, you are going to be held to the highest standard of accountability."

As the legislative session approaches, the battle lines are being drawn between the investment firms and a coalition of parents, advocates, and state lawmakers. The outcome of this fight will likely serve as a bellwether for other states struggling to reconcile the demands of the private equity market with the duty to provide safe, reliable healthcare to their most vulnerable citizens.

For the families currently navigating the system, the hope is that these reforms will finally put the focus back where it belongs: on the children, not the bottom line.